Content about WellSpring Pharmaceutical Corp.

May 1, 2013

Prasco Labs has signed a deal with WellSpring Pharmaceutical Corp. to market an authorized generic version of a drug for a rare tumor disorder.

CINCINNATI — Prasco Labs has signed a deal with WellSpring Pharmaceutical Corp. to market an authorized generic version of a drug for a rare tumor disorder.

The company announced Wednesday the distribution and supply agreement for phenoxybenzamine hydrochloride capsules in the 10 mg strength for pheochromocytoma, an adrenal gland tumor disorder. The drug is used to control episodes of hypertension and sweating associated with the disorder.

November 7, 2011

Sentinel Capital Partners has acquired Sarasota, Fla.-based WellSpring Pharmaceutical, the private equity firm said Monday.

NEW YORK — Sentinel Capital Partners has acquired Sarasota, Fla.-based WellSpring Pharmaceutical, the private equity firm said Monday.

Sentinel, which describes itself as investing in lower middle-market companies, said it bought the manufacturer of prescription and OTC drugs, which manufactures its products in Ontario, alongside Ancor Capital Partners. Financial terms of the deal were not disclosed.